Helixgate https://validator.w3.org/feed/docs/rss2.html A star scientist showed that better genetics lessons could reduce racism. It was the death knell for his career STAT+: Small drugmakers, facing threat of tariffs, negotiate pricing deals with White House Home Opinion: STAT+: Former Geisinger CEO: U.S. health systems must replace huge numbers of people with AI  AI model designs new treatment candidate for opioid addiction that cuts cravings in rats Microplastics in Human Bile Drive Mitochondrial Dysfunction and Senescence STAT+: Health insurers score major win with higher 2027 Medicare Advantage rates CRISPR at 25: The Past, Present, and Future of Genome Editing Gungnir codec enabling high error-tolerance and low-redundancy DNA storage through substantial computing power Immunotherapy Enhanced by Restoring Mitochondrial Function in Dendritic Cells Hims & Hers says limited data stolen in social engineering attack Proposed FDA budget sets Makary up to boost US biotech Amgen seeks to buoy Tepezza with injectable data in face of incoming competition STAT+: A key Medicare Advantage announcement is due today Pharma’s dealmaking tear; Blackstone raises record fund; Xolair energizes allergy research; and more  Machine Learning and Single-Cell Technology Combined to Drive High-Performance Cell Line Development Anthropic pays $400M for biotech; Praxis epilepsy drug hits in Phase 1/2 trial Takeda ends partnership with Denali amid restructuring STAT+: Pharmalittle: We’re reading about an FDA delay forcing a biotech to close, a Neurocrine deal, and more Pharma Pipeline Stalls for First Time in Decades: Citeline Nuclera launches GPCR-focused nanodisc panel  Nanotube Injector Boosts Mitochondrial Performance Through Cytoplasmic Transfer STAT+: Neurocrine Biosciences to buy Soleno Therapeutics in $2.9B deal Neurocrine will pay $2.9B for Soleno and its Prader-Willi medicine Stipple Bio launches with $100M to find more precise targets on cancer proteins Perks persuade participants Opinion: ‘Medical nutrition’ helps keep my son, and many others, healthy. But insurance won’t cover it Biotech Looks to Replimune RP1 Decision as ‘First Indicator’ of FDA Direction FDA Reversals in Rare Disease Space Highlight Confusion Around External Controls StockWatch: Price War Dampens Lilly Surge After Oral GLP-1 Wins FDA Nod Injectable Microgel Developed to Reduce Bleeding in Infants Undergoing Surgery Epigenetic Strategy Restores Tumor Suppressor in Acute Myeloid Leukemia Models Hydrogel-Based Axon Model Improves Early Testing for MS Remyelination Therapies STAT+: Medicare Advantage plans win extra $18.6 billion as feds cut star ratings measures EPA to put microplastics on study list of contaminants in drinking water AI In Silico Multi-Omics Technique Cuts Therapeutic Development Costs OpenLoop Health has acquired nutrition startup Season Health Top 10 Organoid Companies Trump signs order to put 100% pharma tariffs on drugs, countries without trade deals STAT+: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along Trump revives pharma tariffs with 100% charges, but leaves loopholes STAT+: Up and down the ladder: The latest comings and goings White House floats 12.5% budget cut for HHS in FY2027, reiterates reorganization plan STAT+: Pharmalittle: We’re reading about Trump’s drug tariffs, a U.S.-U.K. pharma trade deal, and more This week in Drug Discovery (30 March – 3 April)  BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the Blow Months after $100M series A, Syneron closes $150M round to support peptide platform Supreme Court conversion therapy decision could ripple through medicine Pharma’s M&A Train Is on Track for Record Highs With More Deals To Come: Analysts